Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

India court rejects cancer drug patent bid

Residents in India's capital New Delhi form long queues at this pharmacy. The country is home to a drugs market that grows between 13 and 14 percent every year, making it an attractive investment for Western pharmaceutical companies. But a landmark court ruling could change that. On Monday, India's top court rejected a bid by Swiss drug-maker Novartis to win patent protection for its cancer drug, Glivec. (SOUNDBITE) (English) ADVOCATE FOR RANBAXY, PRATIBHA M SINGH, SAYING: "The Supreme Court judgment today in the Novartis case is that Novartis' appeal has been dismissed." The court said the drug could not be patented as a new medicine because the formula was based on an amended version of a known compound. Activists have welcomed the decision, saying many Indians cannot afford branded medicines. (SOUNDBITE) (English) MANAGER, MEDECINS SANS FRONTIERES (MSF), LEENA MENGHANEY, SAYING: "It's a huge relief because we have more than 200,0

© DailyMotion -

Comment on this article!
To post a comment, we encourage you to become a member of® or log in if you are already a member. You can still post your commentwithout registering, but you will need to fill your personal information each time.

Become a member (free)   |   Log in

Postings are subject to the terms and conditions of®. Before submitting your message , you must read the Terms and conditions of® and agree to them by checking the box below.
Your name:
  I have read and agree to the Terms and conditions of®.
Follow us on ...
Facebook Twitter